Introduction
Two experienced groups analysing the same well-conducted study using well-known statistical methods came to dramatically different conclusions which they debate in a scientific journal. How can this happen?
From the results obtained, Cederberg et al.
(1) of the Swedish Chemicals Agency concluded that tetrachloroethylene is weakly genotoxic in the liver of CD1 mice by inducing significant DNA damage in hepatocytes. They say 'tetrachloroethylene induced a weak but statistically significant and doserelated increase in DNA damage in the liver'. This has led to an exchange of letters (2, 3) .
The study director at Covance who carried out the study concluded that tetrachloroethylene did not induce DNA damage in the liver and kidney of mice in the same experiment and that the size of the effects observed was not big enough to indicate any DNA-damaging effects (2). Lillford et al. noted that 'this conclusion was heavily dependent on statistical analysis', that there is no consensus on the statistical analysis of comet assay data and that the Organization for Economic Cooperation and Development's guidelines state that 'statistical significance should not be the only criterion for conclusion of a positive result'.
The argument between the contractor and the client thus depends very much upon their choice of statistical methods for analysing the data. (In this case, unusually, the client is arguing for a positive 'call'; the contract laboratory for a negative call).
The original paper (1) and subsequent correspondence (2,3) raise many interesting arguments. In this Commentary, at the risk of generating further debate, I have made some comments that may help bring some light instead of heat to this disagreement and explain why both groups make relevant statistical points but also some less strong ones.
I argue here that an appreciation of the statistical issues around the analysis of data helps the interpretation rather than hinders it. Statistics is both the science of dealing with uncertainty and the technology of extracting information from data (4). Statistical analysis is rightly part of the interpretation of an experimental design. However, the role of a statistical analysis is not just to identify a statistically significant result. The equating of statistical significance with statistical analysis has long been criticised by professional statisticians. Frank Yates, for instance, is credited with accidentally introducing the star nomenclature in a paper in the 1930s. In his obituary (5), it is said that 'Yates placed great emphasis on the estimation of effects, together with relevant measures of uncertainty, but the tendency of experimenters to pursue statistical significance as an end in itself [an unintended result of Fisher's work on analysis of variance (ANOVA)] has not been fully eliminated even now, as many present-day journals show clearly'. It is an irony that 75 years after Yates' paper was published, arguments amongst biologists over statistical significance persist.
One example is the consequence of using statistical significance as a decision criterion for calling a result either a positive or a negative finding. Such dichotomisation may have advantages from a regulatory perspective but also creates both false positive and false negative results (referred to by some as misleading positives and negatives). It also results in an ill-defined criterion for how to classify real but weak effects. A full statistical analysis can help put some of this uncertainty into perspective.
Discussion of study results
The experiment (1) was basically quite simple. There seems no dispute that it was a well-conducted alkaline comet assay. Six male mice in each group were exposed orally to tetrachloroethylene at doses of 0 (vehicle control), 1000 and 2000 mg/kg/day. Four slides were prepared per tissue (with 100 cells scored per animal). Individual animal data are provided in the paper. The animal was correctly considered as the experimental unit.
Cederberg et al. (1) argue that a significant result was obtained in the statistical analysis of the median values of the tail intensity data for each animal using the exact permutation method one-sided Jonckheere-Terpstra (J-T) test (P 5 0.041) with, presumably, an appropriate dose metric. They argue that this is a weak but real effect and that this dose-related response was strong evidence for biological relevance. No effect was seen with the kidney data. No statistically significant differences were found for the tail moment data in either tissue. The positive controls were clearly positive.
Lillford et al. (2) argue that their approach of carrying out an ANOVA followed by an unspecified test for dose-response and pairwise Dunnett's tests against the negative concurrent control was more powerful and more efficient than the use of a non-parametric procedure. They stated that they found no significant outcomes.
However, my re-analysis of the data using SPSS indicated that a one-sided test for linear trend was significant at P 5 0.032. This test is a parametric test similar to the J-T test. The J-T was also significant at P 5 0.041 using SPSS (with a log dose metric with 0, 3.0 and 3.3 as the dose levels).
It is not clear from their letter whether Lillford et al. (2) used an omnibus test (i.e. a test of the difference between groups) in their analysis. If they did, this may explain why they failed to find a significant trend. It is probably not correct that such an omnibus ANOVA or the non-parametric equivalent Kruskal-Wallis test is more powerful than a test for linear trend. The J-T seems a legitimate test of the null hypothesis of no trend. The J-T test is a non-parametric or distribution-free test for 'ordered alternatives' or a monotonic trend similar to the test for the linear component of a betweengroups comparison for parametric data. (It is important to note that different results can be obtained with trend tests depending upon the choice of the dose metric to use.) Nonparametric tests are slightly less powerful than their parametric equivalents but potentially give a more accurate Type I error rate when the assumptions underlying parametric tests are violated.
Multiple comparisons
There are important statistical issues around the use of pairwise tests and multiple comparison methods such as Dunnett's test. Cederberg et al. (1) argue that ' . . . the procedure relying on multiple pairwise comparisons, used by the Study Director, has less power for analysis of this type of results when there is a monotone dose response than the step-down approach used by us'. While this is broadly correct, it is not clear what their 'step-down approach' was.
A multiple comparison procedure, in effect, 'dampens' down the number of significant results reported. The Bonferroni correction, for instance, is a highly conservative method, some of the others less so, but often to an unknown degree while taking no or limited account of the actual study design such as the inclusion of a dose comparison. The Dunnett's test, for instance, was developed for designs with a number of test compounds/chemicals and a common control to minimise the risk of falsely identifying a compound as better than the existing standard. It may not be best suited for use with studies explicitly designed to detect dose-response relationships. Dunnett's test has the property that when a comparison is declared significant, at say P 5 0.05, there is only a 5% error that a series or 'family' of such comparisons will wrongly contain an incorrect declaration of significance when there is, in fact, no difference.
In a sense, this 5% 'family-wide' error rate of Dunnett's test 'damps' down the significance level so that differences have to be appreciably bigger to be classified as significant than using a method such as the Least Significant Difference (LSD) test (equivalent to the t-test with pooled within-group variances), which does not include a multiple comparison approach. This critical difference increases as the number of groups included in the design increases.
The different approaches used by the two groups illustrate the contrast between a powerful trend test of a specific hypothesis and a conservative multiple comparison method. It is not a question of one test being right, the other wrong; it is a case of understanding the different hypotheses being tested. The results of the different tests are not contradictory; rather they represent the properties of the different tests. The real question is the size of the effect observed not the statistical significance. The use of statistical significance to create a decision rule to make a dichotomy creates a problem for the interpretation of the results.
Multiple comparisons are, however, an issue in this study. There were (at least) two organs and two end points investigated. Only one comparison of the tissue/end points is statistically significant using a powerful statistical test, with the correlated measure, tail moment, not significant. It could be argued that there should be some consideration of whether a multiple comparison correction should have been applied. If so, this would have altered the interpretation of the borderline significance level seen with the tail intensity measure.
Some consideration should also be given to how many comparisons were originally planned to be carried out (a priori) and how many were carried out following examination of the data (a posteriori/post hoc). In their letter, Cederberg et al. (3) refer to making a choice of the statistical test to use after an examination of the data. This could be criticised because such an approach could affect the probability statements about the findings.
The use of the Fisher exact test by Cederberg et al.'s (1) to compare the number of 'high' animals in the treatment groups compared with the control animals is a less convincing part of their argument. This is a post hoc test carried out after the J-T test had already been found to be significant. It is not surprising that there are significantly more high scoring animals in the dosed groups than the control group because this is another way of looking at the data that has already been identified as being significant using the J-T tests. The two tests are not independent and the Fisher exact test provides little extra corroboration of the results of the J-T test.
There is a high correlation between the two comet scores-tail moment and tail intensity-in both liver and kidney (r 5 0.93 and r 5 0.89, respectively; P , 0.001 in both cases). The failure by Cederberg et al. (1) , therefore, to detect a significant effect with tail moment weakens the evidence from the analysis of the tail intensity data.
An analysis of this data using the LSD test showed, however, a significant difference at P 5 0.05 in the comparison of the medium dose with the negative control but not with the top dose for the liver tail moment data (P values of 0.047 and 0.088, respectively, in a two-sided test). This was despite the data in Table 1 of Cederberg et al. (1) showing the two groups having the same mean! The difference is a consequence of rounding the mean values. This again illustrates the difficulties that can arise if statistical significance at P 5 0.05 was the sole criterion used as a decision criterion to describe a result as positive or negative. (Note that both comparisons would have been significant at P , 0.05 if a onesided test had been used.)
The use of the historical control data may have only limited value. Both groups argue that it supports their view. However, much of the data were from rats, although the study data seemed to be close to or within historical control data for mice. This was argued by Lillford et al. (2) as part of the case for the biological basis. This could though also be indicative of a weak effect rather than a strong argument for no effect.
Size of effect and further studies
Both groups agree that any effects are small. Lillford et al. (2) argue that the highest increase was 1.43-fold (tail intensity) higher than vehicle control, while for tail moment, the largest increase was 1.36-fold. Cederberg et al. argue that 'The established statistically significant dose-related increase in tail intensity in the liver provides a strong argument for the biological relevance of the effect'. This seems a little strong given the 'borderline' significance, the potential multiple comparison issues, the limitations of the 'confirmatory' Fisher's exact test and the relatively small size of the effect.
Cederberg et al. suggest a repeat study should be carried out to 'reduce the scope of possible discordant interpretations of the results'. However, if an experiment has been considered equivocal, then repeating the experiment (same design, protocol, etc.) should give a similar result.
This initial experiment is a sample of one from the population of all the possible experiments of the same design that could have been done. This single result is, therefore, somewhere on the hypothetical distribution of possible results and gives the 'best' estimate of the true state. In practice, it could be very close to the true or expected value, but it could also be near the upper extreme of the distribution of a low effect or the lower end of a high difference.
If, though, the experiment is repeated because concern has been awakened by the results as they are in some way surprising, unusual, unexpected or controversial, it is possible that the initial experimental result is at one end of the extremes or 'tails' of the possible results that could have been obtained. Consequently, the second experiment is more likely to be near the true result and will not be as pronounced as the initial study. This is an example of 'regression to the mean' or the 'Winner's Curse', a cause of publication bias often detected in funnel plots in meta-analyses.
The way forward is to follow Yates's recommendation. In this experiment, it is not whether one of the comparisons is statistically significant but how big the effect is and how biologically important it is. The issue is, therefore, not really about what statistical test should be used but rather what is the size of effect that is considered to represent a positive effect. If the objective of the assay is to 'make a call' of whether the compound is 'positive' or 'negative', then this is dichotomising an end point (e.g. %tail DNA) that is measured on a continuum into either a þve or a Àve result. This 'cut-off' point needs to be made on the basis of expert judgement not on whether a test is statistically significant or not.
One approach is to consider the power associated with a statistical test for such a study by identifying an effect size (ES). The ES is the size of difference it is hoped to observe divided by an estimate of the variability (the between animal standard deviation). The values for the standard deviations from the vehicle control group (Table 1 (Table 2 of Cederberg et al. (2)). A simple power calculation for 80% power for a one-sided test at P 5 0.05 for n 5 6 gives an effect size of 1.54; for 90% power, this is 1.82. (The ESs for a twosided test at P 5 0.05 for 80 and 90% power are 1.79 and 2.08, respectively.) The ES is interpreted as the size of effect that would be detected 80% of the time using the statistical test at a P value of 0.05 if this size of difference actually existed. Using this approach, it is possible to get an idea of the size of effects that are detectable at a high probability using a particular design and to assess how biologically important such effects are.
One consequence of a design is that it will also be able to detect effects smaller than the ES but with lower power. The design will then be capable of detecting real but small effects, which while statistically significant are considered biologically unimportant (i.e. a negative call). There may be options, for instance, such as developing decision rules based upon the outcomes of more than one statistical test or of choosing more stringent critical values for the statistical tests, but these will still have consequences in terms of false-positive and false-negative calls. There may also be issues about interpretation of data, such as the interpretation of non-linear dose responses possibly resulting from toxicity, which needs to be based upon expert judgement rather than solely upon statistical criteria.
Some concluding remarks
The paper (1) and the subsequent letters (2,3) raise interesting statistical issues. The key result from this study is an effect in one end point with borderline significance using a powerful statistical test. A number of other comparisons did not reach significance.
It is not possible from this single experiment to say whether the finding represents a small but real genotoxic effect or is a false-positive result as a consequence of a Type 1 statistical error. The result, however, illustrates the problems that arise from trying to dichotomise a result using a decision criteria based upon a statistical test reaching a certain level of statistical significance. Not surprisingly, there may be disagreement over the interpretation.
A more appropriate approach is to give an estimate of the size of the effect with some measure of the confidence associated with it (such as, an increase of 0.000192 tail intensity U/mg/kg/day of tetrachloroethylene with two-sided 95% confidence limits of À0.000008 to 0.000391). Such an estimate then gives information more useful to an assessment of the genotoxicity of the compound allowing the statistical information, together with other considerations about the nature of the study design, to be included into the assessment.
Finally, statistical input into both the design and assessment of the results is critical for the biological interpretation of a study. However, statistical significance should not be the sole determinant of the interpretation of a result. Statistical analysis and biological interpretation should be complementary not contradictory.
